器官移植受者非结核分枝杆菌病临床诊疗技术规范（2019版）

中华医学会器官移植学分会

doi:10.3969/j.issn.1674-7445.2019.04.004

器官移植受者非结核分枝杆菌病临床诊疗技术规范（2019版）

doi: 10.3969/j.issn.1674-7445.2019.04.004

中华医学会器官移植学分会^,

510012 广州医科大学附属第一医院（巨春蓉）；中国人民解放军总医院第八医学中心（石炳毅）

基金项目:

国家自然科学基金 81570680

国家自然科学基金 81571555

详细信息

通讯作者:
巨春蓉，女，1977年生，博士，主任医师，研究方向为实体器官移植术后肺部并发症，Email: juchunrongju@126.com

中图分类号: R617, R378.91
计量
- 文章访问数: 284
- HTML全文浏览量: 119
- PDF下载量: 64
- 被引次数: 0
出版历程
- 收稿日期: 2019-04-23
- 网络出版日期: 2021-01-19
- 刊出日期: 2019-07-15

Technical specification for clinical diagnosis and treatment of nontuberculosis mycobacteria in organ transplant recipients (2019 edition)

Branch of Organ Transplantation of Chinese Medical Association^,

摘要

摘要: 为了进一步规范实体器官移植（SOT）术后非结核分枝杆菌（NTM）病的诊断和治疗，中华医学会器官移植学分会组织器官移植学专家和感染学专家，从SOT术后受者NTM感染的流行病学特点、SOT术后NTM病的特点及分类、SOT术后NTM病的诊断及鉴别诊断、NTM感染的预防、NTM病的治疗等方面，制订实体器官移植术后NTM病诊疗技术规范。
- 器官移植 /
- 非结核分枝杆菌 /
- 感染 /
- 鸟-胞内分枝杆菌 /
- 脓肿分枝杆菌 /
- 堪萨斯分枝杆菌 /
- 阿奇霉素

HTML全文

参考文献(24)

[1]	VAN INGEN J. Diagnosis of nontuberculous mycobacterialinfections[J]. Semin Respir Crit Care Med, 2013, 34(1):103-109. DOI: 10.1055/s-0033-1333569.
[2]	GEORGE IA, SANTOS CA, OLSEN MA, et al. Epidemiology and outcomes of nontuberculous mycobacterial infections in solid organ transplant recipients at a midwestern center[J]. Transplantation, 2016, 100(5):1073-1078. DOI: 10.1097/TP.0000000000001123.
[3]	LONGWORTH SA, DALY JS, AST Infectious Diseases Community of Practice. Management of infections due to non-tuberculous mycobacteria in transplant recipients - guidelines from the American Society of Transplantation Infectious Diseases Community of Practice[J]. Clin Transplant, 2019, 11: e13588. DOI: 10.1111/ctr.13588.
[4]	ADJEMIAN J, DANIEL-WAYMAN S, RICOTTA E, et al. Epidemiology of nontuberculous mycobacteriosis[J]. Semin Respir Crit Care Med, 2018, 39(3):325-335. DOI: 10.1055/s-0038-1651491.
[5]	WU J, ZHANG Y, LI J, et al. Increase in nontuberculous mycobacteria isolated in Shanghai, China: results from a population-based study[J]. PLoS One, 2014, 9(10):e109736. DOI: 10.1371/journal.pone.0109736.
[6]	马玙, 黄海荣.浅议非结核分枝杆菌肺病的诊断[J].中华结核和呼吸杂志, 2012, 35(8):564-566. DOI: 10.3760/cma.j.issn.1001-0939.2012.08.003. MA Y, HUANG HR. Diagnosis of pulmonary disease of non-tuberculosis mycobacterium[J]. Chin J Tuberc Respir Dis, 2012, 35(8):564-566. DOI: 10.3760/cma.j.issn.1001-0939.2012.08.003.
[7]	SHAH SK, MCANALLY KJ, SEOANE L, et al. Analysis of pulmonary non-tuberculous mycobacterial infections after lung transplantation[J]. Transpl Infect Dis, 2016, 18(4):585-591. DOI: 10.1111/tid.12546.
[8]	ISHⅡ K, ISHⅡ N, NAKANAGA K, et al. Mycobacterium haemophilum infection with prominent facial manifestation mimicking leprosy[J]. J Dermatol, 2015, 42(10):992-995. DOI: 10.1111/1346-8138.12948.
[9]	ANANDH U, JAYANNA K. Nontubercular mycobacterial infection in a renal allograft recipient[J]. Indian J Nephrol, 2017, 27(6):478-481. DOI: 10.4103/ijn.IJN_336_16.
[10]	NAKAMURA Y, YOSHIOKA D, MIYAGAWA S, et al.A case of mycobacterium chelonae mediastinitis and acute humoral rejection after heart transplantation[J]. J Card Surg, 2019, 34(4):205-207. DOI: 10.1111/jocs.13997.
[11]	MAHMOOD M, AJMAL S, ABU SALEH OM, et al. Mycobacterium genavense infections in non-HIV immunocompromised hosts: a systematic review[J]. Infect Dis (Lond), 2018, 50(5):329-339. DOI: 10.1080/23744235.2017.1404630.
[12]	OMBELET S, VAN WIJNGAERDEN E, LAGROU K, et al. Mycobacterium genavense infection in a solid organ recipient: a diagnostic and therapeutic challenge[J]. Transpl Infect Dis, 2016, 18(1):125-131. DOI: 10.1111/tid.12493.
[13]	CAHUAYME-ZUNIGA LJ, BRUST KB. Mycobacterial infections in patients with chronic kidney disease and kidney transplantation[J]. Adv Chronic Kidney Dis, 2019, 26(1):35-40. DOI: 10.1053/j.ackd.2018.09.004.Review.
[14]	WILMES D, COCHE E, RODRIGUEZ-VILLALOBOS H, et al. Bacterial pneumonia in kidney transplant recipients[J]. Respir Med, 2018, 137:89-94. DOI: 10.1016/j.rmed.2018.02.022.
[15]	DUCHARLET K, MURPHY C, TAN SJ, et al. Recurrent mycobacterium haemophilum in a renal transplant recipient[J]. Nephrology (Carlton), 2014, 19 (Suppl 1):14-17. DOI: 10.1111/nep.12193.
[16]	DOWDELL K, HAIG SJ, CAVERLY LJ, et al. Nontuberculous mycobacteria in drinking water systems - the challenges of characterization and risk mitigation[J]. Curr Opin Biotechnol, 2019, 57:127-136. DOI: 10.1016/j.copbio.2019.03.010.
[17]	HENKLE E, WINTHROP KL. Nontuberculous mycobacteria infections in immunosuppressed hosts[J]. Clin Chest Med, 2015, 36(1):91-99. DOI: 10.1016/j.ccm.2014.11.002.
[18]	KANG YA, KOH WJ. Antibiotic treatment for nontuberculous mycobacterial lung disease[J]. Expert Rev Respir Med, 2016, 10(5):557-568. DOI: 10.1586/17476348.2016.1165611.
[19]	YOO JW, JO KW, KIM SH, et al. Incidence, characteristics, and treatment outcomes of mycobacterial diseases in transplant recipients[J]. Transpl Int, 2016, 29(5):549-558. DOI: 10.1111/tri.12752.
[20]	JANKOVIC MAKEK M, PAVLISA G, JAKOPOVIC M, et al. Early onset of nontuberculous mycobacterial pulmonary disease contributes to the lethal outcome in lung transplant recipients: report of two cases and review of the literature[J]. Transpl Infect Dis, 2016, 18(1):112-119. DOI: 10.1111/tid.12481.
[21]	ANDRÉJAK C, ALMEIDA DV, TYAGI S, et al. Characterization of mouse models of mycobacterium avium complex infection and evaluation of drug combinations[J]. Antimicrob Agents Chemother, 2015, 59(4):2129-2135. DOI: 10.1128/AAC.04841-14.
[22]	DRUMMOND WK, KASPERBAUER SH. Nontuberculous mycobacteria: epidemiology and the impact on pulmonary and cardiac disease[J]. Thorac Surg Clin, 2019, 29(1):59-64. DOI: 10.1016/j.thorsurg.2018.09.006.
[23]	SANTOS-SILVA A, PEREIRA F, GAIO R, et al. Differential risk factors for slowly and rapidly-growing nontuberculous mycobacteria: a retrospective cross-sectional study[J]. Pulmonology, 2019, 25(2):114-116. DOI: 10.1016/j.pulmoe.2018.12.003.
[24]	TISSOT A, THOMAS MF, CORRIS PA, et al. Nontuberculous mycobacteria infection and lung transplantation in cystic fibrosis: a worldwide survey of clinical practice[J]. BMC Pulm Med, 2018, 18(1):86. DOI: 10.1186/s12890-018-0635-3.